Do analysts recommend JF or BKYI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score J And Friends 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BIO-key International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, JF or BKYI?

J And Friends has higher earnings, but lower revenue than BIO-key International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio J And Friends $1.60M 12.09 -$1.32M N/A N/A BIO-key International $6.10M 0.73 -$4.59M -$5.55 N/A

Do analysts rate AIFF or BKYI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BIO-key International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer AIFF or BKYI?

In the previous week, BIO-key International had 1 more articles in the media than Firefly Neuroscience. MarketBeat recorded 2 mentions for BIO-key International and 1 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 1.36 beat BIO-key International's score of 0.34 indicating that Firefly Neuroscience is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Firefly Neuroscience 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BIO-key International 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer BKYI or MNDO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BIO-key International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 MIND C.T.I. 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend BKYI or ELWS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BIO-key International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Earlyworks 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, BKYI or ELWS?

Earlyworks has higher revenue and earnings than BIO-key International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BIO-key International $6.10M 0.73 -$4.59M -$5.55 N/A Earlyworks $440.36M 0.04 -$1.80M N/A N/A

Do analysts recommend BKYI or VRAR?

The Glimpse Group has a consensus price target of $2.62, suggesting a potential upside of 217.88%. Given The Glimpse Group's stronger consensus rating and higher possible upside, analysts plainly believe The Glimpse Group is more favorable than BIO-key International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BIO-key International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 The Glimpse Group 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

BIO-key International (BKYI) Competitors

$4.10 0.00 (0.00%)

As of 07/2/2026 01:35 PM Eastern

Compare

BKYI vs. JF, AIFF, MNDO, ELWS, and VRAR

Should you buy BIO-key International stock or one of its competitors? MarketBeat compares BIO-key International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BIO-key International include J And Friends (JF), Firefly Neuroscience (AIFF), MIND C.T.I. (MNDO), Earlyworks (ELWS), and The Glimpse Group (VRAR). These companies are all part of the "computer software" industry.

How does BIO-key International compare to J And Friends?

J And Friends (NASDAQ:JF) and BIO-key International (NASDAQ:BKYI) are both small-cap computer software companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

J And Friends has higher earnings, but lower revenue than BIO-key International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
J And Friends	$1.60M	12.09	-$1.32M	N/A	N/A
BIO-key International	$6.10M	0.73	-$4.59M	-$5.55	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
J And Friends	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BIO-key International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, BIO-key International had 2 more articles in the media than J And Friends. MarketBeat recorded 2 mentions for BIO-key International and 0 mentions for J And Friends. BIO-key International's average media sentiment score of 0.34 beat J And Friends' score of 0.00 indicating that BIO-key International is being referred to more favorably in the news media.

Company	Overall Sentiment
J And Friends	Neutral
BIO-key International	Neutral

J And Friends has a net margin of 0.00% compared to BIO-key International's net margin of -75.32%. J And Friends' return on equity of 0.00% beat BIO-key International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
J And Friends	N/A	N/A	N/A
BIO-key International	-75.32%	-67.43%	-43.29%

6.6% of J And Friends shares are held by institutional investors. Comparatively, 26.5% of BIO-key International shares are held by institutional investors. 4.1% of J And Friends shares are held by company insiders. Comparatively, 3.9% of BIO-key International shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

J And Friends has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market. Comparatively, BIO-key International has a beta of 0.44, suggesting that its stock price is 56% less volatile than the broader market.

Summary

J And Friends beats BIO-key International on 7 of the 11 factors compared between the two stocks.

How does BIO-key International compare to Firefly Neuroscience?

Firefly Neuroscience (NASDAQ:AIFF) and BIO-key International (NASDAQ:BKYI) are both small-cap computer software companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends.

Firefly Neuroscience has a beta of 0.55, indicating that its stock price is 45% less volatile than the broader market. Comparatively, BIO-key International has a beta of 0.44, indicating that its stock price is 56% less volatile than the broader market.

BIO-key International has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than BIO-key International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Firefly Neuroscience	$1.14M	17.66	-$19.88M	-$0.63	N/A
BIO-key International	$6.10M	0.73	-$4.59M	-$5.55	N/A

5.0% of Firefly Neuroscience shares are owned by institutional investors. Comparatively, 26.5% of BIO-key International shares are owned by institutional investors. 6.4% of Firefly Neuroscience shares are owned by company insiders. Comparatively, 3.9% of BIO-key International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

BIO-key International has a net margin of -75.32% compared to Firefly Neuroscience's net margin of -565.40%. BIO-key International's return on equity of -67.43% beat Firefly Neuroscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-565.40%	-94.68%	-73.51%
BIO-key International	-75.32%	-67.43%	-43.29%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Firefly Neuroscience	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BIO-key International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, BIO-key International had 1 more articles in the media than Firefly Neuroscience. MarketBeat recorded 2 mentions for BIO-key International and 1 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 1.36 beat BIO-key International's score of 0.34 indicating that Firefly Neuroscience is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Firefly Neuroscience	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BIO-key International	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

BIO-key International beats Firefly Neuroscience on 8 of the 13 factors compared between the two stocks.

How does BIO-key International compare to MIND C.T.I.?

BIO-key International (NASDAQ:BKYI) and MIND C.T.I. (NASDAQ:MNDO) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability.

26.5% of BIO-key International shares are owned by institutional investors. Comparatively, 24.3% of MIND C.T.I. shares are owned by institutional investors. 3.9% of BIO-key International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

MIND C.T.I. has higher revenue and earnings than BIO-key International. BIO-key International is trading at a lower price-to-earnings ratio than MIND C.T.I., indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BIO-key International	$6.10M	0.73	-$4.59M	-$5.55	N/A
MIND C.T.I.	$19.46M	1.12	$2.60M	$0.14	7.71

In the previous week, BIO-key International had 2 more articles in the media than MIND C.T.I.. MarketBeat recorded 2 mentions for BIO-key International and 0 mentions for MIND C.T.I.. BIO-key International's average media sentiment score of 0.34 beat MIND C.T.I.'s score of 0.00 indicating that BIO-key International is being referred to more favorably in the media.

Company	Overall Sentiment
BIO-key International	Neutral
MIND C.T.I.	Neutral

BIO-key International has a beta of 0.44, suggesting that its share price is 56% less volatile than the broader market. Comparatively, MIND C.T.I. has a beta of 0.39, suggesting that its share price is 61% less volatile than the broader market.

MIND C.T.I. has a net margin of 15.26% compared to BIO-key International's net margin of -75.32%. MIND C.T.I.'s return on equity of 13.20% beat BIO-key International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BIO-key International	-75.32%	-67.43%	-43.29%
MIND C.T.I.	15.26%	13.20%	10.00%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BIO-key International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
MIND C.T.I.	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

MIND C.T.I. beats BIO-key International on 9 of the 14 factors compared between the two stocks.

How does BIO-key International compare to Earlyworks?

BIO-key International (NASDAQ:BKYI) and Earlyworks (NASDAQ:ELWS) are both small-cap computer software companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BIO-key International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Earlyworks	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

26.5% of BIO-key International shares are owned by institutional investors. Comparatively, 0.5% of Earlyworks shares are owned by institutional investors. 3.9% of BIO-key International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Earlyworks has a net margin of 0.00% compared to BIO-key International's net margin of -75.32%. Earlyworks' return on equity of 0.00% beat BIO-key International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BIO-key International	-75.32%	-67.43%	-43.29%
Earlyworks	N/A	N/A	N/A

In the previous week, BIO-key International had 2 more articles in the media than Earlyworks. MarketBeat recorded 2 mentions for BIO-key International and 0 mentions for Earlyworks. BIO-key International's average media sentiment score of 0.34 beat Earlyworks' score of 0.00 indicating that BIO-key International is being referred to more favorably in the media.

Company	Overall Sentiment
BIO-key International	Neutral
Earlyworks	Neutral

Earlyworks has higher revenue and earnings than BIO-key International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BIO-key International	$6.10M	0.73	-$4.59M	-$5.55	N/A
Earlyworks	$440.36M	0.04	-$1.80M	N/A	N/A

BIO-key International has a beta of 0.44, suggesting that its share price is 56% less volatile than the broader market. Comparatively, Earlyworks has a beta of 1.73, suggesting that its share price is 73% more volatile than the broader market.

Summary

Earlyworks beats BIO-key International on 6 of the 11 factors compared between the two stocks.

How does BIO-key International compare to The Glimpse Group?

BIO-key International (NASDAQ:BKYI) and The Glimpse Group (NASDAQ:VRAR) are both small-cap computer software companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

In the previous week, BIO-key International had 2 more articles in the media than The Glimpse Group. MarketBeat recorded 2 mentions for BIO-key International and 0 mentions for The Glimpse Group. BIO-key International's average media sentiment score of 0.34 beat The Glimpse Group's score of 0.00 indicating that BIO-key International is being referred to more favorably in the media.

Company	Overall Sentiment
BIO-key International	Neutral
The Glimpse Group	Neutral

The Glimpse Group has higher revenue and earnings than BIO-key International. The Glimpse Group is trading at a lower price-to-earnings ratio than BIO-key International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BIO-key International	$6.10M	0.73	-$4.59M	-$5.55	N/A
The Glimpse Group	$9.49M	1.83	-$2.55M	-$0.18	N/A

The Glimpse Group has a net margin of -50.18% compared to BIO-key International's net margin of -75.32%. The Glimpse Group's return on equity of -24.98% beat BIO-key International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BIO-key International	-75.32%	-67.43%	-43.29%
The Glimpse Group	-50.18%	-24.98%	-21.99%

BIO-key International has a beta of 0.44, meaning that its stock price is 56% less volatile than the broader market. Comparatively, The Glimpse Group has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market.

26.5% of BIO-key International shares are held by institutional investors. Comparatively, 21.4% of The Glimpse Group shares are held by institutional investors. 3.9% of BIO-key International shares are held by company insiders. Comparatively, 17.1% of The Glimpse Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

The Glimpse Group has a consensus price target of $2.62, suggesting a potential upside of 217.88%. Given The Glimpse Group's stronger consensus rating and higher possible upside, analysts plainly believe The Glimpse Group is more favorable than BIO-key International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BIO-key International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
The Glimpse Group	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

The Glimpse Group beats BIO-key International on 12 of the 16 factors compared between the two stocks.

Get BIO-key International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BKYI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BKYI vs. The Competition

Export

Metric	BIO-key International	ELEC PRODS Industry	Computer Sector	NASDAQ Exchange
Market Cap	$4.45M	$18.85B	$38.43B	$12.46B
Dividend Yield	N/A	1.10%	3.18%	6.50%
P/E Ratio	-0.59	33.82	169.78	24.70
Price / Sales	0.73	124.70	618.92	98.68
Price / Cash	N/A	60.20	45.62	57.09
Price / Book	0.40	7.83	9.55	6.46
Net Income	-$4.59M	$401.74M	$1.07B	$337.01M
7 Day Performance	-10.87%	-1.99%	1.13%	1.36%
1 Month Performance	-7.45%	7.67%	-2.42%	1.68%
1 Year Performance	-49.75%	42.15%	143.60%	23.97%

BIO-key International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BKYI BIO-key International	0.2309 of 5 stars	$4.10 flat	N/A	-49.7%	$4.45M	$6.10M	N/A	50	Gap Up
JF J And Friends	0.1582 of 5 stars	$1.08 +1.4%	N/A	N/A	$19.73M	$1.60M	N/A	78	Gap Up
AIFF Firefly Neuroscience	0.3069 of 5 stars	$1.26 -3.8%	N/A	-59.2%	$19.71M	$1.14M	N/A	N/A	News Coverage Positive News Gap Down
MNDO MIND C.T.I.	1.531 of 5 stars	$0.95 flat	N/A	-21.2%	$19.35M	$19.46M	6.79	160
ELWS Earlyworks	N/A	$5.86 -5.6%	N/A	+75.1%	$17.86M	$440.36M	N/A	15	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BKYI) was last updated on 7/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BIO-key International (BKYI) Competitors

BKYI vs. JF, AIFF, MNDO, ELWS, and VRAR

How does BIO-key International compare to J And Friends?

Summary

How does BIO-key International compare to Firefly Neuroscience?

Summary

How does BIO-key International compare to MIND C.T.I.?

Summary

How does BIO-key International compare to Earlyworks?

Summary

How does BIO-key International compare to The Glimpse Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BKYI vs. The Competition

BIO-key International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BIO-key International (BKYI) Competitors

BKYI vs. JF, AIFF, MNDO, ELWS, and VRAR

How does BIO-key International compare to J And Friends?

Which has stronger earnings & valuation, JF or BKYI?

Do analysts recommend JF or BKYI?

Does the media favor JF or BKYI?

Is JF or BKYI more profitable?

Do insiders and institutionals believe in JF or BKYI?

Which has more risk & volatility, JF or BKYI?

Summary

How does BIO-key International compare to Firefly Neuroscience?

Which has more volatility & risk, AIFF or BKYI?

Which has stronger valuation & earnings, AIFF or BKYI?

Do insiders & institutionals hold more shares of AIFF or BKYI?

Is AIFF or BKYI more profitable?

Do analysts rate AIFF or BKYI?

Does the media prefer AIFF or BKYI?

Summary

How does BIO-key International compare to MIND C.T.I.?

Do institutionals & insiders have more ownership in BKYI or MNDO?

Which has higher valuation & earnings, BKYI or MNDO?

Does the media refer more to BKYI or MNDO?

Which has more volatility & risk, BKYI or MNDO?

Is BKYI or MNDO more profitable?

Do analysts prefer BKYI or MNDO?

Summary

How does BIO-key International compare to Earlyworks?

Do analysts recommend BKYI or ELWS?

Do institutionals and insiders have more ownership in BKYI or ELWS?

Is BKYI or ELWS more profitable?

Does the media prefer BKYI or ELWS?

Which has better valuation and earnings, BKYI or ELWS?

Which has more risk and volatility, BKYI or ELWS?

Summary

How does BIO-key International compare to The Glimpse Group?

Does the media refer more to BKYI or VRAR?

Which has stronger valuation and earnings, BKYI or VRAR?

Is BKYI or VRAR more profitable?

Which has more volatility and risk, BKYI or VRAR?

Do institutionals and insiders hold more shares of BKYI or VRAR?

Do analysts recommend BKYI or VRAR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BKYI vs. The Competition

BIO-key International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools